Gene: EDEM2
Official Full Name: ER degradation enhancing alpha-mannosidase like protein 2provided by HGNC
Gene Summary: In the endoplasmic reticulum (ER), misfolded proteins are retrotranslocated to the cytosol and degraded by the proteasome in a process known as ER-associated degradation (ERAD). EDEM2 belongs to a family of proteins involved in ERAD of glycoproteins (Mast et al., 2005 [PubMed 15537790]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18070 | EDEM2 Knockout cell line (HeLa) | Human | EDEM2 | 1:3~1:6 | Negative | Online Inquiry |
KO18071 | EDEM2 Knockout cell line (HCT 116) | Human | EDEM2 | 1:2~1:4 | Negative | Online Inquiry |
KO18072 | EDEM2 Knockout cell line (HEK293) | Human | EDEM2 | 1:3~1:6 | Negative | Online Inquiry |
KO18073 | EDEM2 Knockout cell line (A549) | Human | EDEM2 | 1:3~1:4 | Negative | Online Inquiry |
EDEM2 Gene Knockout Cell Lines are genetically engineered cell models designed to facilitate the study of endoplasmic reticulum-associated degradation (ERAD) and protein quality control. By creating specific deletions in the EDEM2 gene, these cell lines allow researchers to investigate the functions of EDEM2 in the degradation of misfolded glycoproteins and the overall dynamic mechanisms of the ERAD pathway.
The primary function of EDEM2 involves the recognition and binding of misfolded proteins, promoting their retrotranslocation to the cytoplasm for proteasomal degradation. By utilizing the EDEM2 Gene Knockout Cell Lines, scientists can elucidate the critical roles this protein plays in maintaining cellular homeostasis and its implications in diseases associated with protein misfolding, such as neurodegenerative disorders and certain cancers.
In a research or clinical context, these cell lines provide a valuable tool for screening potential therapeutic agents, validating drug targets, and understanding the biochemical pathways involved in protein folding and degradation. Their utility extends to basic molecular biology studies and translational applications, where insights gained may lead to novel therapeutic interventions.
Compared to traditional wild-type cell lines, the knockout model offers a distinctive advantage by eliminating confounding variables associated with EDEM2 expression, thus delivering more accurate results in experimental setups. Moreover, these cell lines can be easily manipulated to assess the effects of other mutations or drug treatments, making them a versatile addition to any laboratory focused on cellular biology or pharmacology.
The EDEM2 Gene Knockout Cell Lines are indispensable for researchers and clinicians looking to advance their understanding of protein homeostasis mechanisms and explore potential therapeutic avenues. With a commitment to innovation and quality, our company specializes in providing high-caliber biological products, ensuring that our clients have access to tools that empower groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.